111 Inc. Expands National Supply Chain Network with New Fulfillment Centers across South and Central China
SHANGHAI, Oct. 10, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain of healthcare industry by digitally empowering the upstream and downstream in China, today announced that new fulfillment centers in South and Central China began operations in Guangzhou, Guangdong Province, and Wuhan, Hubei...
Qantev raises €30 million from Blossom Capital to continue building the world’s most advanced AI-driven claims platform for health and life insurers
PARIS, Oct. 10, 2024 /PRNewswire/ -- Qantev – the most advanced AI-powered platform transforming how health and life insurers manage claims, reduce costs and improve services – has raised €30 million in a new funding round led by Blossom Capital, with participation from existing investors Elaia, Omnes and RAISE Venture. Qantev is the leading AI...
Nobel laureate Professor Michael Levitt shares his journey in science with students and staff at XJTLU
SUZHOU, China, Oct. 10, 2024 /PRNewswire/ -- On 8 October, Xi'an Jiaotong-Liverpool University (XJTLU) welcomed Nobel laureate Professor Michael Levitt for an engaging science talk. He delivered the talk, A Wonderful Life in Science, both onsite and to a worldwide online audience.  XJTLU Master Forum | “A Wonderful Life in Science” by Professor Michael Levitt Professor Levitt, a...
Harbour BioMed Announces Publication of the Phase I Study Results for Porustobart in Combination with Toripalimab in Advanced Melanoma and Other Solid Tumors
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SUZHOU, China, Oct. 10, 2024 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery, development, and commercialization of novel antibody therapeutics focusing on oncology and immunology, today announced the online publication of the results from its phase I clinical trial of...
Acer Medical: VeriOsteo OP Obtains Medical Device Approval from Indonesia’s Ministry of Health
TAIPEI, Oct. 10, 2024 /PRNewswire/ -- Acer Medical announced that its AI-assisted bone mineral density abnormalities screening software, VeriOsteo OP, has obtained a medical device certificate from Indonesia's Ministry of Health. This marks the second product to receive registration approval, following the certification of the VeriSee DR, an AI-assisted diagnostic solution for diabetic retinopathy VeriSee DR. ...
Daewoong Pharmaceutical Unveils ‘Innovative Drug Delivery Technologies’ in Milan–From World’s First Microneedle Therapy to Once-a-Month Obesity Treatment
MILAN, Oct. 10, 2024 /PRNewswire/ -- Daewoong Pharmaceutical (Co-CEOs Seongsoo Park and Chang-jae Lee) announced on the 9th that they will present their cutting-edge drug delivery technologies, including the world's first microneedle-based drugs, at 'CPHI Worldwide 2024'—the world's largest pharmaceutical and biotech exhibition—held in Milan, Italy. In addition, Daewoong will continue to...
Centivax Selects Global CDMO BioCina to Initiate cGMP Manufacturing of Revolutionary Universal Influenza Vaccine
ADELAIDE, South Australia, Oct. 9, 2024 /PRNewswire/ -- BioCina Pty Ltd., a global end-to-end biologics Contract Development and Manufacturing Organization (CDMO), announced a new partnership with Centivax, Inc., for a project involving cell line development, cell banking and plasmid DNA manufacture. Centivax is developing Cent-Flu, a universal influenza vaccine, consisting of a proprietary multivalent mixture of 22 unique mRNA...
Arbele Announces Strategic Collaborations on AI Precision Oncology and Manufacturing to Advance CDH17-Targeted Immunotherapeutics
SEATTLE, Oct. 9, 2024 /PRNewswire/ -- Arbele, a leading innovator in biopharmaceutical & biotechnology focused on targeting cadherin-17 (CDH17), is pleased to announce strategic collaborations in precision oncology using artificial intelligence (AI) to advance targeted immunotherapeutics of bispecific T-cell engagers (TCEs) and antibody-drug conjugates (ADCs). These partnerships, aimed at advancing the quantification and prognostic prediction of CDH17 expression in tumor...
Inaugural Health and Wellbeing Forum Discussed about Co-creating Healthier Hong Kong for all
This event brought together over 60 representatives from patient organizations, academia, and healthcare community to explore the possibilities of achieving maximum health equity in Hong Kong HONG KONG, Oct. 9, 2024 /PRNewswire/ -- Pfizer Hong Kong held its inaugural "Health & Well-being Forum" to discuss important issues on social health equity and mental...
ZEISS expands ophthalmic offerings to improve patient care with new digital AI tools and revolutionary surgical solutions
Showcasing at AAO 2024: ZEISS VisioGen offers a cutting-edge, AI-driven solution designed to enhance refractive patient communication and streamline clinic operations. ZEISS Milestone: Celebrating more than 10 million eyes treated with lenticule extraction solutions utilizing ZEISS SMILE and ZEISS SMILE pro. ZEISS marked its 25th year of leadership in defining...
